EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Caffeine for Persistent Intermittent Hypoxia in Newborns With and Without Chronic Lung Disease

Aurore Côté iD, Phoukim Savanh, Wissam Shalish iD, Victoria Bizgu, Anne-Marie Canakis

Pediatric Pulmonology · 2025

DOI: 10.1002/ppul.71312 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Pulmonology, 2025. Verfasst von Aurore Côté und 4 weiteren Autor:innen. Beteiligte Einrichtung: Respiratory Medicine Division, Room B-RC-5155, The Montreal Children's Hospital, Montreal, Québec, Canada. Hauptthemen laut MEDLINE: Caffeine, Hypoxia, Lung Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To assess the caffeine response in preterm and term newborns with persistent intermittent hypoxia (IH) as they approach discharge, with particular focus on newborns with chronic lung disease of prematurity (CLD). To identify factors associated with a lack of response to caffeine. Design/Settings Retrospective cohort study across two neonatal intensive care units between 2015 and 2022. Main Outcomes Following Caffeine Administration Normal oximetry; no need for respiratory support; resolution of hypercapnia.

Results

A total of 132 infants received caffeine for persistent IH. Normal oximetry was achieved post‐caffeine in 81% (46/57) of newborns with CLD, in 96% (46/48) of preterm with no CLD, in 96% (26/27) of term newborns. Caffeine reduced the % time with SpO 2 < 90% from 6.8% (interquartile range, 3.8%–12.2%), to 0.8% (0.4%–1.6%, p < 0.0001). The desaturation index < 80% dropped from 5.3 events/hour (0.9–14.6 events/hour) to 0.2 events/hour (0–0.78 events/hour, p < 0.0001) and the desaturation index ≥ 10% lasting > 10 s went from 6.6 events/hour (3.3–10.7 events/hour) to 1.4 events/hour (0.7–2.4 events/hour, p < 0.0001). Of the 61 infants on respiratory support, 74% (45/61) were weaned within a few days following caffeine. Caffeine normalized PCO 2 in 63% (41/65) of newborns with elevated PCO 2 pre‐caffeine. Infants failing caffeine were more likely to have CLD compared to responders (79% vs. 39%, p < 0.005). Caffeine was successfully discontinued (first attempt, normal oximetry) in 101 infants (88%) at postmenstrual age of 46.1 weeks (45.3–48.3 weeks).

Conclusion

Caffeine improved respiratory outcomes in the majority of preterm and term born infants with persistent IH, including those with CLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CaffeineHypoxiaLung DiseasesHumansInfant, NewbornRetrospective StudiesFemaleMaleInfant, PrematureOximetryIntensive Care Units, NeonatalChronic DiseaseHypercapnia

Stichwörter der Autor:innen

hypercapniaoximetryventilator support

Substanzen

Caffeine

Autor:innen und Institutionen

  • Respiratory Medicine Division, Room B-RC-5155, The Montreal Children's Hospital, Montreal, Québec, Canada.
  • Neonatology Division, The Jewish General Hospital, Montréal, Québec, Canada.
  • Neonatology Division, The Montreal Children's hospital, Montreal, Québec, Canada.
  • Respiratory Medicine Division, The Montreal Children's Hospital, Montreal, Québec, Canada.

ORCID-Profile: Aurore Côté, Wissam Shalish

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Côté, A., Savanh, P., Shalish, W., Bizgu, V., & Canakis, A. M. (2025). Caffeine for Persistent Intermittent Hypoxia in Newborns With and Without Chronic Lung Disease. Pediatric Pulmonology. https://doi.org/10.1002/ppul.71312

Vancouver

Côté A, Savanh P, Shalish W, Bizgu V, Canakis AM. Caffeine for Persistent Intermittent Hypoxia in Newborns With and Without Chronic Lung Disease. Pediatric Pulmonology. 2025. doi:10.1002/ppul.71312

BibTeX
@article{Ct2025,
  author = {Côté, Aurore and Savanh, Phoukim and Shalish, Wissam and Bizgu, Victoria and Canakis, Anne-Marie},
  title = {Caffeine for Persistent Intermittent Hypoxia in Newborns With and Without Chronic Lung Disease},
  journal = {Pediatric Pulmonology},
  year = {2025},
  doi = {10.1002/ppul.71312}
}
Kostenlos starten →